1. U.S. Food and Drug Administration. 2013. Vaccines, blood & biologics. U.S. Food and Drug Administration, Bethesda, MD. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833.
2. U.S. Food and Drug Administration. 2010. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S. Food and Drug Administration, Bethesda, MD. http://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm202439.pdf.
3. Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus
4. U.S. Food and Drug Administration. 2012. FDA briefing document: Vaccines and Related Biological Products Advisory Committee meeting: cell lines derived from human tumors for vaccine manufacture. U.S. Food and Drug Administration, Bethesda, MD. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM319573.pdf.
5. Cell lines derived from late embryonic stages of Drosophila melanogaster;Schneider I;J. Embryol. Exp. Morphol.,1972